Circulating microRNAs (miRNA) are relatively stable in plasma and are a new class of disease biomarkers. Here we present evidence that high-density lipoprotein (HDL) transports endogenous miRNAs and delivers them to recipient cells with functional targeting capabilities. Cellular export of miRNAs to HDL was demonstrated to be regulated by neutral sphingomyelinase. Reconstituted HDL injected into mice retrieved distinct miRNA profiles from normal and atherogenic models. HDL delivery of both exogenous and endogenous miRNAs resulted in the direct targeting of messenger RNA reporters. Furthermore, HDL-mediated delivery of miRNAs to recipient cells was demonstrated to be dependent on scavenger receptor class B type I. The human HDL-miRNA profile of normal subjects is significantly different from that of familial hypercholesterolemia subjects. Notably, HDL-miRNA from atherosclerotic subjects induced differential gene expression, with significant loss of conserved mRNA targets in cultured hepatocytes. Collectively, these observations indicate that HDL participates in a mechanism of intercellular communication involving the transport and delivery of miRNAs.
Until recently, the predominant view of intercellular communication was that it was limited to cell-to-cell adhesion conduits (gap junctions) or secreted signals, such as hormones and neurotransmitters. New studies have revealed that plasma-membrane-derived vesicles, namely exosomes and microvesicles, can transfer proteins, mRNAs and miRNAs from donor cells to recipient cells [1] [2] [3] [4] . miRNAs are short non-coding regulatory RNAs that modulate biological homeostasis by controlling gene expression through mRNA targeting and translational repression [5] [6] [7] . Circulating miRNAs are a new class of biomarkers and have recently been used for a diverse set of diseases 8 .
Specific lipids found on lipoproteins, such as phosphatidylcholine, have been shown to form stable ternary complexes with nucleic acids [9] [10] [11] . Infrared spectrometry, small-angle X-ray scattering and other physical techniques have demonstrated that the interaction between RNA-DNA with zwitterionic lipids is mediated by divalent cation bridging [9] [10] [11] [12] [13] [14] [15] . A wide variety of nucleic acid-lipid complexes have been used for the delivery of genetic material to cells both in vitro and in vivo. In fact, liposomes containing apolipoprotein A-I (apoA-I), the main protein component of HDL, have been used for the systemic and specific delivery of small interfering RNA (siRNA) in animal models 13 .
The resemblance of these artificial gene delivery vehicles to native HDL and the biophysical interaction between nucleic acids with HDL phospholipids combined with the existence of circulating miRNAs prompted us to investigate whether endogenous miRNAs are associated with HDL in plasma. In this study, we present evidence that HDL not only transports endogenous miRNAs, which can differ with disease states, but can also deliver miRNAs to recipient cells with functional gene regulatory consequences. This study, therefore, reveals a potential previously unknown role for HDL in gene regulation and intercellular communication.
RESULTS

Human HDL contains small RNAs
Highly purified fractions of HDL were prepared from human plasma in a three-step protocol, consisting of density-gradient ultracentrifugation (DGUC; d = 1.063-1.21 g ml −1 ), followed by fast-protein liquid chromatography (FPLC), and anti-apoA-I immunoprecipitation (HDL immunoprecipitation). Exosomes, which have a density (d = 1.13-1.19 g ml −1 ) similar to HDL, are significantly larger in size (50-100 nm) than HDL (8-12 nm) and thus should be effectively removed by FPLC gel filtration, as well as by HDL immunoprecipitation 16, 17 . The FPLC profile of human plasma (Fig. 1a ) was used to define relative size zones associated with HDL (red), low-density lipoprotein (LDL; green) and very low-density lipoprotein (VLDL) or exosomes (blue). The FPLC profile of purified HDL (red line) illustrates the absence of any particles larger than HDL (Fig. 1a) , and the distribution of total cholesterol in the FPLC fractions further validates the purity of isolated HDL particles (Fig. 1b) . HDL isolated by the three-step sequential procedure was observed by transmission electron microscopy (TEM) to be of uniform size (10-12 nm) and shape (Fig. 1c ). Purified HDL particles were enriched for apoA-I (Fig. 1d) , and were negative for classic exosomal protein 4  20  40  80 100  150  60   0 4 8 12  40  36  32  28  24  20  16  52 56 60  44 48  64  0 4 8 12  40  36  32  28  24  20  16 52 56 markers heat-shock protein 70 (HSP70; Fig. 1e ), CD63 ( Fig. 1f ) and intercellular adhesion molecule 1 (ICAM-1; Supplementary  Fig. S1a ; refs 18-20) . Total RNA, isolated from highly purified HDL, contained small RNAs ( Fig. 1g -i), but was devoid of long mRNAs. Fluorescence quantification (RiboQuant) of gel-extracted HDL-RNA, 15 to 30 nucleotides in length, confirmed the presence of small RNA in the purified HDL pool ( Supplementary Fig. S1b ). The small-RNA fraction is most likely miRNA, as evidenced by its approximate length (22-26 nucleotides) observed in RNA gels, Bioanalyzer small-RNA characterization ( Fig. 1g-i) , and the presence of the widely expressed miRNA, hsa-miR-223, in purified HDL ( Fig. 1j; refs 21, 22) .
Distinct HDL-miRNA signature in disease
Total RNA was isolated from highly purified HDL from normal and familial hypercholesterolemia subjects ( Supplementary Table S1 ). HDL-miRNA profiles were analysed using an amplification-based microarray platform (Applied Biosystems) and normalized abundances of HDL-miRNAs were ranked (values were normalized to the mean threshold cycle, Ct, for each individual array; Table 1 and Supplementary Table S2 ). The most abundant miRNAs associated with HDL from normal subjects were hsa-miR-135a * (relative quantitative value, RQV = 121.9), hsa-miR-188-5p (RQV = 17.1) and hsa-miR-877 (RQV = 11.1), and all three were in the top ten rankings for all normal subjects ( Table 1 ). Most importantly, the normal HDL-miRNA profile was distinctly different (R = 0.4598,P < 0.0001) from the purified exosome-miRNA profile ( Supplementary Table S3 ) from matched subjects ( Supplementary Fig. S1c ), including differences in content, abundances and top-ranked miRNAs.
The most abundant familial hypercholesterolemia HDL-miRNAs were hsa-miR-223 (RQV = 3,014,553), hsa-miR-105 (RQV = 13,671.6) and hsa-miR-106a (RQV = 437.8; Table 1 ). HDL from familial hypercholesterolemia subjects had a greater concentration of the most prominent miRNAs ( Fig. 2a ,b) and contained more individual miRNAs than normal subjects (99-74, ≥3 calls per group; Fig. 2c ). For example, the most abundant familial hypercholesterolemia HDL-miRNA, hsa-miR-223, was the fourth most abundant miRNA associated with normal HDL (Table 1) ; however, hsa-miR-223 levels increased 3,780.6-fold with familial hypercholesterolemia disorder (P = 0.019). The frequency of significant and low P values was greater than random distribution, which is indicative of differential HDL-miRNA signatures in health and disease ( Fig. 2d ). Furthermore, HDL-miRNA signatures from normal and diseased (familial hypercholesterolemia) subjects were determined to be distinct (R = 0.2253, P < 0.0001; Fig. 2e ). A volcano plot shows that 22 HDL-miRNAs were significantly (P < 0.05) differentially (twofold) abundant on HDL from familial hypercholesterolemia subjects, not including miRNAs that were completely unique (ON-OFF) for each condition (Fig. 2f ).
Each strand of a duplex miRNA, processed from the pre-miRNA, has the potential to be a distinct functional miRNA. Expression ratios of the two strands are variable and the active strand can originate from both the 5p and 3p end of the precursor hairpin. To investigate the HDL-miRNA expression (abundance) ratios, we analysed the ratio of mature miRNAs (miR) and their less abundant duplex strands (miR * ), including analysis of 5p to 3p miRNA ratios ( Fig. 2g -i). Our array platform allowed for the analysis of 197 miRNA pairs; however, only ten pairs were observed in HDL from normal subjects, with a mean ratio (absolute fold change) of 17. Similar abundance levels (absolute fold change <2.0) of both strands were observed in only three of the ten pairs ( Fig. 2g,i) . Collectively, the abundance levels of both strands were relatively equal in less than 2% of all pairs analysed ( Fig. 2g ,i). Similar results were observed in familial hypercholesterolemia subjects ( Fig. 2h ,i); therefore, miRNA pairs were represented by only one strand on HDL.
LDL has similar physico-chemical properties to HDL; however, LDL is larger in size (22 nm), differs in protein composition, and its generation and maturation are distinct from HDL. Highly pure fractions of LDL were also found to contain miRNAs ( Fig. 3a) . Nonetheless, the LDL-miRNA signature is more closely aligned with the exosome-miRNA signature (R = 0.72, P < 0.0001) than HDL (R = 0.54,P < 0.0001) when quantified in the same subject ( Fig. 3a and Supplementary Table S4 ). Familial hypercholesterolemia, a genetic disorder of the LDL receptor (LDLR), results in extreme atherosclerosis in homozygous cases 23 . As described above, familial hypercholesterolemia subjects exhibit a significantly differential HDL-miRNA profile ( Fig. 2 , Table 1 and Supplementary Table  S2 ), compared with normal subjects. To further investigate this observation, LDLR (Ldlr)-null mice were placed on a high-fat diet (HFD) and the HDL-miRNA profile was compared with that of wild-type controls ( Supplementary Tables S5 and S6) . Similarly to humans, loss of Ldlr resulted in a significant change to the mouse HDL-miRNA profile; however, the total number of miRNAs significantly altered was less in Ldlr −/− mice (5) than in human familial hypercholesterolemia disorder (22; Fig. 3b and Supplementary Tables  S5 and S6 ). Overall, the Ldlr −/− HFD HDL-miRNA profile was less distinct from wild-type controls (R = 0.43,P < 0.0001) than the human familial hypercholesterolemia HDL profile was from normal subjects (R = 0.22,P < 0.0001; Figs 2e and 3c), which may be an indication of the degree of atherosclerosis.
Native HDL incorporates small RNAs in vitro
To observe miRNA bound to native HDL, miR-223 was labelled with 1.4 nm monoamino Nanogold, incubated with human HDL (1 h, 37 • C), and complexes were purified by HDL immunoprecipitation. Gold-enhanced Nanogold-labelled miRNA-HDL complexes were Wild-type mouse HDL-miRNAs 0.01 electron dense and measured to be 9-13 nm in diameter ( Fig. 4a ). Gold enhancement of Nanogold-labelled antibodies on a grid under the same conditions yielded large dense grains, some greater than 100 nm in diameter ( Supplementary Fig. S2a ). This indicates that the Nanogold-labelled miRNA may be buried within the HDL to which it is bound, resulting in reduced exposure to the gold enhancement reagents. To further determine whether miRNAs associate with or bind to native HDL in vitro, radiolabelled [ 32 P]miRNA mimetics were used in FPLC gel-filtration assays. Radiolabelled miRNAs were incubated with HDL at 37 • C, and the complexes were separated by FPLC (S-200 column). The association of miRNA ([ 32 P]miR-125a) with native HDL ([ 3 H]cholesterol, black arrow) was influenced by temperature, as shown by binding at 37 • C versus 20 • C (Fig. 4b) . To quantify HDL-miRNA incorporation, native HDL and reconstituted HDL (rHDL; Supplementary Fig. S2b ) were incubated with miR-223 and HDL-miRNA complexes were isolated by HDL immunoprecipitation. Both native (P = 0.0002) and rHDL contained significantly more miR-223 after complexing in vitro, as determined by quantitative PCR (qPCR; Fig. 4c ). Native human HDL has a natural abundance of endogenous hsa-miR-223; however, rHDL was free of RNA before incorporation assays (Fig. 4c ).
rHDL retrieves miRNAs in vivo
To determine whether rHDL (free of RNA) has the capacity to be loaded with miRNAs in vivo, human rHDL (150 µg) was injected intravenously into wild-type or apolipoprotein E (Apoe −/− )-null micefed normal chow or HFD. After 6 h post-injection, rHDL was recovered from mouse plasma by anti-human apoA-I immunoprecipitation and mouse miRNAs were profiled by amplification-based microarrays. Injected rHDL retrieved 110, 162 and 130 unique miRNAs from wild-type, Apoe −/− chow and Apoe −/− HFD plasma, respectively ( Table 1 , Supplementary Table S7 and Fig. S3 ). Although wild-type and Apoe −/− HFD mice shared 92 HDL-miRNAs, the profiles were distinct and the levels of the most abundant miRNAs were greatly altered in the atherosclerosis mouse model (Apoe −/− HFD; Supplementary Fig. S3b , Table 1 and Supplementary Table S7 ). HDL-miRNA profiling of rHDL isolated from Apoe −/− mice on chow diet was used to determine whether HDL-miRNA signature changes were associated with vascular arterial disease or simply hyperlipidemia, although hypercholesterolemia ultimately results in atherogenesis. The HDL-miRNA profile from Apoe −/− HFD mice was determined to be significantly different from those of wild-type and Apoe −/− chow mice ( Supplementary Fig. S3c,d) . Taken together these results indicate that HDL binds to miRNAs in vivo and that atherosclerosis in mice results in altered HDL-miRNA signatures.
Homology between human and mouse HDL profiles
Although miR-223 is one of the most abundant HDL-miRNAs in mice and humans, its concentration was increased 3.2-fold in Apoe −/− HFD mice, 4.2-fold in Ldlr −/− HFD mice and 3,780-fold with familial hypercholesterolemia when compared with controls (Table 1 , Supplementary Table S1 -S7 and Fig. S3 ). miR-24 was also increased in both Apoe −/− HFD (9.13-fold) and familial hypercholesterolemia (65.3-fold), compared with controls. Furthermore, miR-211 was not detectable in HDL fractions from either normal subjects or wild-type mice; however, miR-211 was abundant in Apoe −/− HFD and familial hypercholesterolemia HDL (Table 1) . Conversely, miR-135a * , one of the most abundant miRNAs observed on HDL, was reduced in humans (−2.41-fold) and mice (Apoe −/− HFD −1.9−fold) with atherosclerosis ( Table 1) . To assess homology between the representative groups of health and disease (atherosclerosis), the complete mean miRNA profiles were filtered to only miRNAs conserved between humans and mice. The mean abundances of the conserved miRNAs were significantly correlated (R = 0.682, P < 0.0001) between healthy groups (normal humans and wild-type mice; Fig. 4d ). Hierarchal clustering of the filtered mean HDL profiles from all assayed conditions (n = 7) resulted in the separation of the familial hypercholesterolemia profile; however, the human familial hypercholesterolemia profile was most tightly clustered with the Apoe −/− HFD mouse profile (Fig. 4e) . Similarly, the normal human, Apoe −/− chow, and wild-type mouse profiles were clustered furthest from the familial hypercholesterolemia signature. Furthermore, 11 miRNAs, conserved between humans and mice, were found on HDL of every healthy subject or mouse analysed ( Supplementary Table S8 ). These data indicate that both humans and mice transport a consistent group of conserved miRNAs on HDL in wellness and disease.
HDL transfers miRNAs to recipient cells
To investigate the mechanisms of miRNA export to HDL, we examined the role of ATP-binding cassette transporter A1 (ABCA1) and neutral sphingomyelinase 2 (nSMase2) pathways. Biogenesis of HDL is mediated through ABCA1 cellular efflux of cholesterol and phospholipids to nascent HDL (ref. 24) . To test whether ABCA1 mediates the efflux of small RNAs during the maturation of HDL, we induced overexpression of ABCA1 with the Liver-X-Receptor-α (LXRα) agonist TO90131. J774 mouse macrophages were treated with 10 µM TO90131 and rHDL (10 µg ml −1 ) in lipoprotein-depleted serum (LPDS). After 48 h, rHDL was isolated from culture media by anti-human apoA-I immunoprecipitation and total RNA was purified. qPCR was used to measure the levels of exported miR-223 as normalized to rHDL-immunoprecipitation total protein. The addition of rHDL alone facilitated the export of miR-223 and the induction of ABCA1 by TO90131 increased the abundance of miR-223 on rHDL 1.8-fold (P = 0.16) ( Fig. 5a ). Recently, a study has demonstrated that inhibition of the ceramide signalling pathway through GW4869 chemical inhibition of nSMase2 resulted in the attenuation of cellular miRNA export by exosomes and a significant reduction of specific extracellular miRNAs (ref. 25) . To determine whether nSMase2 regulates the export of miRNAs to HDL, J774 macrophages were treated with 10 µM GW4869 for 48 h. Contrary to previous results obtained in HEK293 cells measuring exosomal miRNAs, inhibition of nSMase2 significantly increased the amount of miR-223 exported to HDL (35.3-fold, P = 0.035) from macrophages. Tandem mass spectrometry and western blotting failed to identify previously described miRNA binding proteins on HDL, including nucleophosmin and Argonaute family members ( Supplementary Fig. S4b and Table S9 ).
To test whether HDL has the capacity to deliver small RNAs to recipient cells, native HDL was incorporated with exogenous miRNAs and introduced to cultured hepatocytes (Huh7). In cells treated with HDL-miR-375 complexes, intracellular levels of miR-375 increased 11.8-fold (P = 0.01; Fig. 5b ). Cellular delivery of HDL incorporated with miR-223 also significantly (P = 0.012) increased intracellular miR-223 levels (250-fold; Fig. 5c ), which resulted in the significant loss of miR-223 mRNA targets (Fig. 5d,e ). miR-223 has recently been experimentally validated to target the Ras homologue gene family, member B (RhoB) with two 3 -untranslated region (3 UTR) seed target sites 26 . In our study, overexpression of miR-223 in hepatocytes by transient transfection (100 nM) confirmed the direct targeting of RhoB by miR-223 (60% loss, P < 0.05; Supplementary Fig. S4a ). More importantly, delivery of miR-223 by HDL also reduced RHOB mRNA levels by 53% (P = 0.003; Fig. 5d ). Ephrin A1 (EFNA1), a glycosylphosphatidylinositol (GPI)-anchored receptor tyrosine kinase ligand expressed in the liver and upregulated in hepatocarcinoma, also harbours a conserved miR-223 seed target site within its 3 UTR (ref. 27 ). In our study, HDL-mediated miR-223 delivery resulted in a significant (P = 0.005) 76% loss of EFNA1 mRNA (Fig. 5e ). Taken together, these results indicate that native HDL can readily associate with exogenous small RNAs and deliver genetic material to recipient cells with functional targeting capabilities, leading to altered gene expression.
HDL-miRNA delivery is dependent on scavenger receptor class B type I
To test whether HDL-miRNAs are selectively transferred by scavenger receptor class B type I (SR-BI), loss-of-function and gain-of-function studies were used. Baby hamster kidney (BHK) cells, which do not express significant quantities of SR-BI, were stably transfected with an inducible human SR-BI vector. Both non-induced and induced BHK cells were incubated with native human HDL (10 µg ml −1 ) or HDL-miR-223 complexes for 48 h in LPDS. Intracellular levels of hsa-miR-223 were 69-fold higher (P = 0.0007) in SR-BI-expressing cells treated with HDL-miR-223 complexes, compared with those of HDL alone ( Fig. 6a and Supplementary Fig. S5a) . In siRNA knockdown studies, loss of SR-BI resulted in a significant reduction (89% loss, P = 0.014) of HDL-miR-223 delivery, as quantified by intracellular miR-223 levels (Fig. 6b ). To determine whether SR-BI-dependent HDL-miRNA delivery results in the direct targeting of specific mRNAs, luciferase reporter assays were used in conjunction with the inducible SR-BI system in BHK cells. HDL complexed with exogenous miR-223 directly targeted Renilla-SR-BI-3 UTR luciferase after induced SR-BI-dependent HDL delivery (P = 0.0036; Fig. 6c ). SR-BI harbours a highly conserved miR-223 target site within its 3 UTR ( Supplementary  Fig. S4c ). Interestingly, native human HDL delivered sufficient concentrations of endogenous miRNAs, most likely miR-223, to significantly (P = 0.0014) repress the Renilla-SR-BI-3 UTR luciferase reporters in SR-BI-expressing cells (Fig. 6c) . These results indicate that HDL delivery of both endogenous and exogenous miRNAs through the SR-BI receptor alters gene expression. SID1 transmembrane family member 1 (SIDT1), has previously been demonstrated to mediate the uptake of extracellular double-stranded RNA and cholesterolconjugated siRNAs (refs 28,29) . However, SIDT1 (siRNA) knockdown failed to result in a significant loss of HDL-miR-223 delivery, as quantified by intracellular miR-223 levels ( Supplementary Fig. S5 ).
Intercellular communication by HDL
In silico target prediction (TargetScan5.1) identified mRNAs that are conserved putative targets of the 22 differentially abundant miRNAs on familial hypercholesterolemia HDL (refs 30,31) . The predicted impact on recipient cell gene expression and phenotype attributed to familial hypercholesterolemia HDL-miRNA delivery was conceptualized by the familial hypercholesterolemia HDL-miRNA target network interactome (Fig. 7a) . The most significant pathways predicted to be affected consist of multiple inflammation and signalling pathways ( Supplementary Table S10 ). To further examine whether endogenous levels of miRNAs transported on HDL are sufficient to directly alter gene expression in recipient cells, HDL from familial hypercholesterolemia and HDL from normal subjects were used to treat hepatocytes (Huh7). Huh7 cells endogenously express hsa-miR-105 and intracellular levels failed to increase with treatment of normal (healthy) HDL that lacks hsa-miR-105 ( Fig. 7b) . In contrast, treatment with familial hypercholesterolemia HDL, which has abundant levels of hsa-miR-105 (Table 1) , resulted in a significant (P = 0.042) increase in intracellular hsa-miR-105 levels (Fig. 7b ). Familial hypercholesterolemia HDL-miRNA delivery induced significant gene expression changes in human hepatocytes, compared with normal HDL (Fig. 7c ). High-level analysis of the wholegenome microarray data resolved 217 significant (corrected P < 0.05) differentially (>2-fold) expressed genes altered by familial hypercholesterolemia HDL treatment ( Fig. 7c and Supplementary  Table S11 ). Most (87%) of the downregulated genes (79/91) are putative targets of the 22 differentially abundant miRNAs present of familial hypercholesterolemia HDL. Many (32) of the significantly (corrected P < 0.05) downregulated (>2-fold) mRNAs harboured three or more conserved target sites within 3 UTRs for differential familial hypercholesterolemia HDL-miRNAs (Fig. 7d ). Furthermore, 60% of the significantly downregulated mRNAs were putative targets of the familial-hypercholesterolemia-specific hsa-miR-105 ( Fig. 7e ).
DISCUSSION
A key major finding of this study is that HDL transports endogenous miRNAs. Although the classic view of HDL is that it is a delivery vehicle for the return of excess cellular cholesterol to the liver for excretion, a wide variety of other biological functions have recently been ascribed to HDL (refs 32,33) . Furthermore, it is now recognized that HDL is much more complex in terms of differential lipids and proteins that it transports 34 . This study, therefore, has revealed yet another constituent transported by HDL, namely miRNAs, and a possible previously unknown mechanism whereby some of the biological effects of HDL could be mediated. The exact process of how HDL is loaded with miRNAs and what proteins if any facilitate this association are not known; however, small RNAs (25 nucleotides) have previously been shown to complex with zwitterionic liposomes, specifically phosphatidylcholine 35 . Previous biophysical studies indicate that HDL could simply bind to extracellular plasma miRNAs through divalent cation bridging 9, 12, 14, 15, 35 . In these studies, interactions between DNA molecules and zwitterionic phosphatidylcholines resulted in conformational shifts in phosphatidylcholine head groups and subsequent altered orientations of aliphatic chains, thus facilitating the incorporation of the DNA molecules into the protected space 12 . In the case of HDL, this could lead to a tighter association with miRNAs, and could possibly shield bound miRNAs from external RNases 8 . Furthermore, Langmuir monolayer model systems have shown that nucleic acids easily penetrate lipid monolayers at low surface pressures 12 . Owing to its high radius of curvature, HDL has a much lower surface tension than other lipoproteins, which is known to facilitate its binding to several of its other constituents 36 . Results presented here indicate that nSMase2 and most likely the ceramide pathway repress miRNA export to HDL. Overexpression of nSMase2 and activation of the ceramide pathway have previously been shown to induce exosome release from cells and trigger cellular export of miRNAs (refs 25,37) . These results indicate that the export of specific miRNAs through the exosomal pathway and the HDL pathway may be distinct mechanisms, possibly opposing, although both pathways are probably regulated by nSMase2 activity and ceramide synthesis.
One implication of this study is that HDL-miRNAs could potentially serve as diagnostic markers in much the same way that exosome miRNAs have been used [38] [39] [40] [41] [42] . HDL could simply be a depot or carrier for circulating miRNAs and their presence on HDL may not necessarily relate to the function of HDL in atherosclerosis or lipid metabolism. If so, miRNAs on HDL could perhaps be used diagnostically for a wide variety of diseases besides atherosclerosis. Nonetheless, many of the genes significantly altered in response to atherosclerotic HDL-miRNA delivery have a role in lipid metabolism, inflammation and atherosclerosis, including N-deacetylase/N-sulphotransferase (heparan glucosaminyl) 1 (NDST1; ref. 43 Recently, apoA-I-containing liposomes have been used to deliver siRNAs to the liver, with functional targeting and gene expression changes 13, 47 ; however, the exact mechanism of siRNA transfer from apoA-I liposomes to hepatocytes was not determined. Furthermore, HDL loaded with cholesterol-conjugated siRNAs was shown to be 8-15× more effective in delivering siRNA-mediated silencing than cholesterol-conjugated siRNAs alone 29 . Similarly to our observations in this study for HDL-miRNAs, the delivery of HDL-associated lipophilicconjugated siRNAs was also determined to be SR-BI-dependent 29 . SR-BI-mediated transfer of HDL-miRNAs would probably prevent the delivery of miRNAs into the lysosomal pathway and instead divert it into the cytoplasm where it would be expected to be more stable with increased functional integrity and potential to alter gene expression. Overall these results indicate that artificial HDL delivery strategies that incorporate lipophilic-siRNA conjugates may depend on a naturally occurring lipoprotein-RNA delivery pathway.
One of the most abundant miRNAs that was found in both human and mouse HDL, and increased with atherosclerosis, was the highly conserved miR-223 (ref. 48 ). Expression of miR-223 in various diseases and its effect on biological processes has been extensively investigated 6, 22, 40, [49] [50] [51] . For example, miR-223 has been found to be involved in the regulation of glucose metabolism in cardiomyocytes, cell cycle auto-regulatory loops, ischemia-reperfusion injury, granulopoiesis and osteoclast differentiation 50, [52] [53] [54] [55] CAB39  FSD1L  TBL1XR1  APOOL  FNIP1  MIER3  TARS  CPXCR1  LSM11  G3BP1  CREG2  SLC7A11  BACH1  MAN1A1  GLS  ZBTB10  ITGA4  MAP9  TMEFF2  MBNL2  MIPOL1  KIAA1128  SMEK1  EXOC5  SLC16A7  FBXO32  SENP7  DNM3  SLC30A1  SIX4  RIOK3  IL1RN  CPEB4  CD44  CNOT6L  ARID5B  MAX  TNKS2  PDLIM5  SLC4A7  KLHL24  ACSL1  LCORL  LRP12  LPP  JAK3  ADAMTS17  BMPR2  CDV3  NDST1  PTP4A1  SLC22A15  ZFX  COG3  RP6- CDV3  SLC4A7  RIOK3  PPM1E  PTP4A1  ADAMTS17  SENP7  MBNL2  PCGF5  SLC7A11  LATS2  MAP3K7IP3  NR1D2  LCORL  FAM76B  FLT1  DST  SMEK1  MEF2D  ACSL1  BACH1  LRP12 PIM1 ZBTB10 hepatocellular carcinoma and is a marker for liver cancer 27, 56 . In our study, the delivery of miR-223 by HDL significantly reduced EFNA1 and RHOB mRNA levels in hepatocytes. Taken together, increases in specific intracellular miRNA levels, reduction of specific mRNA targets and the direct repression of luciferase 3 UTR reporters establish that HDL can deliver miRNAs to cells and directly alter gene expression. Furthermore, our results indicate that the delivery of endogenous miRNAs is sufficient to directly target mRNAs and alter gene expression, although some of the observed gene changes from familial hypercholesterolemia HDL treatment could also be related to protein or lipid compositional differences between normal and familial hypercholesterolemia HDL preparations. In summary, a possible previously unknown intercellular communication pathway, involving the transport and cellular delivery of miRNAs by HDL, has been described. This role for HDL potentially elevates lipoproteins to mediators of systemic gene expression apart from their role in cholesterol dynamics. In the version of this Article originally published online, incorrect values appearing in Supplementary Table S4 were used to generate Fig. 3a and to calculate the P and R values. The annotation between Exosome and HDL should have read 'R = 0.22*' , the annotation between Exosome and LDL should have read 'R = 0.63**' and the annotation between HDL and LDL should have read 'R = 0.54**' , where **P < 0.0001 and *P <0.001. The amended Fig. 3a is shown below. These errors have been corrected in the online versions of the Article, and in the Supplementary Information. Vickers Figure S6 
